Tempol alleviates autoimmune uveitis by targeting the oxidative stress-mediated cGAS-STING-NF-kB signaling pathway to restore M1/M2 macrophage polarization balance
Fields of Study & Subjects
interferon and immune responses
Ocular Diseases and Behçet’s Syndrome
Inflammasome and immune disorders
Publication details
- Journal / source
- International Immunopharmacology
- Publisher
- Elsevier BV
- Volume
- 182
- Pages
- 116798–116798
- Publication date
- 8 May 2026
- Language
- EN